The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Trust in your research.........this is huge.......
https://www.fiercebiotech.com/medtech/astrazeneca-applies-ai-to-molecule-building-work-deepmatter-collaboration
Tinzana revealed today that they are using handheld inhalers to administer drugs to Covid19 patients. We have the proven Tech and the drugs are already available. You don’t have to be a rocket scientist to work out what we have here. Good times are surely on the way. Dan will deliver.
This is surely the golden ticket for us especially in these Corona times.....a lot of the small Pharma have jumped onto the bandwagon and the SP have gone ballistic. NFX just need to drop similar on PROVEN drugs and the PROVEN tech to be on the same trajectory shortly. I have faith no matter what the naysayers say.
Agree, Dan said hopeful not imminent and not definitive Q1. Takes as long as it takes. Think about it if he really wanted to raise the SP he could have easily got a Covid19 trial/research RNS out like most other Pharma recently. Still think we will come good and be rewarded for our patience.
2nd that....this and Bango are no brainer stocks in times like these with all the self isolation.
Your right Digital. Excellent opportunity expecting a trading statement this week if last years dates are to go by. Boku released a statement a week ago saying huge increase in spend by end user so think your right in the opportunity here especially after last year when share price grew to £1.50 from these levels.
Stay clear stick with Pharma, good long term bets.
Agree Aim, I have stopped worrying about daily fractional SP movements. I’ve loaded up and locked in. It takes weeks, months or a year. This will pay up I am sure if that. The assets are proven & the BOD are in the game just like us.
Still don’t get why it’s trading close to $4 on NASDAQ we should be £2 at least. Not much free float moves fast.
$3 we are still not half the price of US listing.
London firm seeks green light for vaccine research
Philippa Roxby
Health reporter, BBC News
A company in east London is looking for 24 volunteers to be injected with a strain of the new coronavirus in a bid to find a vaccine against the virus.
It is reported they will be offered up to £3,500 to be infected and then quarantined for two weeks.
But the UK regulator – the Medicines and Healthcare Products Regulatory Agency – still has to agree to the company’s plans before the research can take place.
Research into at least eight vaccines is ongoing in the UK, and scientists in many other parts of the world are also working hard on developing a jab.
It’s unlikely any vaccine will be ready before the end of the year.
Trials to test any potential vaccines must be tested on humans before they can be manufactured and given to the wider public.
Soup, this bit from Dan Got me excited. ‘NXP004 introduces a strong new candidate to our development pipeline which we believe offers significant commercial potential in multiple therapeutic areas.' https://www.share-talk.com/nuformix-plc-lonnfx-ceo-dr-dan-gooding-interview/#gs.yqf3xt. Also the words Significant & multiple. DYOR
I’m also quite excited about the prospect of NXP004, and what that entails. Although the recent update said it was promising didn’t get much of a follow through as of yet. So hopefully we can get some added info which will take this to another level together with the anticipated licensing.